Vietnam Report Joint Stock Company (Vietnam Report) on March 7 announced the top 500 fastest-growing enterprises in Vietnam (FAST500).
Molnupiravir Stella 200mg, a drug from Stellapharm J.V.Co. Ltd., has been authorised by the Drug Administration of Vietnam (DAV) for the domestic treatment of COVID-19.
VOV.VN - Vietnamese pharmaceutical company Stellapharm has been licensed by international public health group Medicines Patent Pool (MPP) to produce Pfizer's COVID-19 treatment pills containing the active ingredient nirmatrelvir.
VOV.VN - The Medicine Patent Pool (MPP) on January 20 announced it has granted licenses to manufacture the COVID-19 treatment drug Molnupiravir to 27 pharmaceutical firms worldwide, including Stella Vietnam (Stellapharm).